z-logo
Premium
Natriuretic peptides as markers of preclinical cardiac disease in obesity
Author(s) -
Grandi A. M.,
Laurita E.,
Selva E.,
Piantanida E.,
Imperiale D.,
Giovanella L.,
Guasti L.,
Venco A.
Publication year - 2004
Publication title -
european journal of clinical investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.164
H-Index - 107
eISSN - 1365-2362
pISSN - 0014-2972
DOI - 10.1111/j.1365-2362.2004.01348.x
Subject(s) - medicine , cardiology , diastole , left ventricular hypertrophy , atrial natriuretic peptide , body mass index , blood pressure , doppler echocardiography , brain natriuretic peptide , natriuretic peptide , ambulatory , obesity , endocrinology , muscle hypertrophy , heart failure
Abstract Background  Aim of the study was to evaluate the role of atrial (ANP) and brain natriuretic peptides (BNP) as markers of preclinical cardiac disease in obesity. Methods  We selected 26 obese (BMI > 29 kg m −2 ) never‐treated hypertensives (24‐h BP > 140 and/or 90 mmHg), 26 obese normotensives (24‐h BP < 130/80 mmHg) and 25 lean (BMI  25 kg m −2 ) never‐treated hypertensives. Each subject underwent measurements of ANP and BNP plasma levels, 24‐h ambulatory blood pressure (BP) monitoring, digitized M‐mode and Doppler echocardiography. Results  Mean values of ANP and BNP were similar among the three groups. All the subjects had normal left ventricular (LV) systolic function. Within each group ANP levels were higher in patients with LV diastolic dysfunction than in patients with normal diastolic function, and BNP levels were higher in patients with LV hypertrophy and in patients with LV diastolic dysfunction. Within each group, ANP levels were inversely correlated with LV diastolic indices, whereas BNP levels were directly correlated with LV mass index and inversely correlated with LV diastolic indices. ANP and BNP levels were not correlated with other echocardiographic parameters, age, BMI or 24‐h BP values. Conclusion  In normotensive and hypertensive obese subjects the relationships of ANP and BNP levels with LV morpho‐functional characteristics follow the same trend as in lean hypertensives, with ANP mainly influenced by diastolic dysfunction and BNP influenced by both LV hypertrophy and LV diastolic dysfunction. Therefore ANP and BNP can be considered useful markers of preclinical cardiac disease in obesity.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here